arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

PALISADE BIO, INC.

PALI

$2.11 ▲ +0.01 (+0.72%) at close

18 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Neutral

auto_awesome

Analytical Summary

PALISADE BIO, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $117.5M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -11.0% ↗

FCF / Share $-0.19 ↗

Trailing P/E —

Price / Book 2.6x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-16.78M

↓ -16.2% —

FCF / Share Free cash flow per share

$-0.19

↑ +97.7% —

Long-Term Debt Long-term obligations

$87.00K

↓ -92.4% —

Health Breakdown

Returns

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	—	N/M	—	—	—	—	-94.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1276%)	0.0% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-100%)	1500.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+18655%)	56.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+599%)	-44.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-659%)	-82.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1136%)	-73.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1013%)	4.4% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-45%)	-46.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-684%)	—	—	—
EPS Growth YoY (%)	97.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-63.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-478.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	23.1% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-16.2% Weak ↓ Weak Declining Year-over-year change in net income	-17.4% Weak ↑ Weak Improving Year-over-year change in net income	13.7% Fair ↑ Fair Improving Year-over-year change in net income	46.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-157.9% Weak ↓ Weak Declining Year-over-year change in net income	-23.6% Weak ↓ Weak Declining Year-over-year change in net income	-69.6% Weak ↓ Weak Declining Year-over-year change in net income	68.6% Excellent ↑ Excellent Improving Year-over-year change in net income	25.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.8% Weak ↑ Weak Improving Year-over-year change in net income	7.6% Fair ↑ Fair Improving Year-over-year change in net income	-14.1% Weak ↑ Weak Improving Year-over-year change in net income	-95.9% Weak ↓ Weak Declining Year-over-year change in net income	19.1% Good ↑ Good Improving Year-over-year change in net income	31.9% Excellent Excellent Year-over-year change in net income	-77.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	97.7% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	64.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-60.8% Weak ↑ Weak Improving Year-over-year change in free cash flow	-857.1% Weak Weak Year-over-year change in free cash flow	7.8% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	-1.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	192.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	139.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-47.1% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-70.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-63.6% Weak Weak Compound annual revenue growth over 3 years	-46.9% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	-0.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	-4.0% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	18.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-8.6% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-47.1% Weak Weak Compound annual revenue growth over 5 years	-57.3% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
FCF / Net Income (x)	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.56x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	0.66x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-11.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-156.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-91.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-99.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-443.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	47.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-133.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-107.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-123.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-143.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-181.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-74.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-115.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-618.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-152.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	164.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-13.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-136.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-93.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-99.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-334.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-307.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-131.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-107.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-95.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-91.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-128.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-58.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-116.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-317.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-143.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-13.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-192.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1385%)	-108.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-825%)	-114.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-862%)	—	62.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+314%)	-162.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1186%)	-81.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-643%)	-184.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1327%)	-186.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1340%)	—	-127.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-951%)	-235.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1671%)	-145.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1068%)	—	-234.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1661%)	206.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1278%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	—	—	—	—	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	-0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-111%)	—	—	—	—	0.68x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+13%)	0.45x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-24%)	0.59x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—
Interest Coverage (x)	-1805.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1238.25x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-871.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1209.31x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-967.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1072.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-83.66x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-18.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.76x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.98x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3763.04x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-15822.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5704.31x Weak Weak Operating income divided by interest expense Optimal: > 5x	-13487.82x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-133.38M	$-9.82M	$-12.43M	$-12.38M	$-10.41M	$428.00K	$-5.11M	$-5.79M	$-6.67M	$-15.19M	$-1.33M	$-4.46M	$-11.91M	$-7.44M	$-2.35M	$-9.26M	$-2.31M	$-4.90M
Debt / EBITDA (x)	—	—	—	—	-0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	-0.18x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.47x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.40x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	$0.55	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.30	$-10.19	$-27.01	$-16.53	$-2.86	$-3.72	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.19	$-8.61	$-24.42	$-15.19	$-1.59	$-1.72	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.81	$2.71	$18.30	$4.24	$0.52	$-5.98	$1.33	$6.65	$0.56	$1.03	$0.70	$0.20	$0.11	$0.10	$0.03	$0.17	—	—
Tangible Book Value per Share (USD)	$0.81	$2.71	$18.30	$4.24	$0.52	$-5.98	$1.15	$5.81	$0.50	$0.94	$0.55	$0.19	$0.09	$0.09	$0.02	$0.16	—	—
Basic Weighted Avg Shares (shares)	55.67M	1.42M	456,014	880,311	9.31M	2.77M	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$129.59M	$7.26M	$10.74M	$11.72M	$9.88M	$-7.19M	$4.42M	$5.46M	$10.93M	$13.57M	$7.01M	$24.15M	$11.68M	$5.90M	$590.38K	$7.09M	—	—
LT Debt (USD)	—	—	—	—	$87.00K	$1.14M	—	—	—	—	$3.38M	$8.06M	$4.93M	$0.00	—	—	—	—
Total Equity (USD)	$129.38M	$7.49M	$11.31M	$12.48M	$7.37M	$-16.60M	$5.13M	$6.05M	$8.52M	$11.33M	$4.97M	$17.72M	$8.42M	$6.97M	$1.66M	$7.85M	$-5.02M	$-2.56M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$250.00K	$0.00	—	—	$15.39K	$260.00K	$260.00K	$16.25K	$10.42K	$18.83K	$110.00K	$407.71K	$390.62K	$733.44K	—	—
Depreciation Expense (USD)	$3.00K	$3.00K	$4.00K	$3.00K	—	—	$49.00K	$84.00K	$100.00K	$161.00K	$148.00K	$137.00K	$126.00K	$101.00K	$104.00K	—	—	—
Net Income, GAAP (USD)	$-16.78M	$-14.44M	$-12.30M	$-14.26M	$-26.62M	$-10.32M	$-8.35M	$-4.92M	$-15.67M	$-21.07M	$-20.90M	$-22.63M	$-19.83M	$-10.12M	$-12.52M	$-18.39M	$-10.36M	—
Operating Cash Flow (USD)	$-10.85M	$-12.19M	$-11.13M	$-13.36M	$-14.77M	$-4.77M	$-7.26M	$-7.69M	$-13.42M	$-15.62M	—	—	—	—	$-8.10M	$-9.98M	$-5.14M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters

PALISADE BIO, INC.

Analytical Summary

18-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare PALI with peers